These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22239439)

  • 21. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
    Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
    Werner H; Sarfstein R; Laron Z
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
    Chakraborty AK; Welsh A; Digiovanna MP
    Breast Cancer Res Treat; 2010 Apr; 120(2):327-35. PubMed ID: 19337828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
    Riedemann J; Sohail M; Macaulay VM
    Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
    Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
    Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies.
    Yap TA; Olmos D; Molife LR; de Bono JS
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1293-304. PubMed ID: 21777167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of molecular agents for IGF receptor targeting.
    Salisbury AJ; Macaulay VM
    Horm Metab Res; 2003; 35(11-12):843-9. PubMed ID: 14710367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
    Blanquart C; Boute N; Lacasa D; Issad T
    Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
    Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
    J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-I receptor inhibition combined with rapamycin or temsirolimus inhibits neuroblastoma cell growth.
    Coulter DW; Blatt J; D'Ercole AJ; Moats-Staats BM
    Anticancer Res; 2008; 28(3A):1509-16. PubMed ID: 18630505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy.
    Zha J; Lackner MR
    Clin Cancer Res; 2010 May; 16(9):2512-7. PubMed ID: 20388853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting insulin-like growth factor 1 receptor in sarcomas.
    Scotlandi K; Picci P
    Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.
    Chan JY; Hackel BJ; Yee D
    Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.